Insights

Recent Expansion Obsidian Therapeutics has secured a significant funding of $161M in Series C financing led by Wellington Management, showing strong financial health and potential for further growth.

Key Personnel Addition Obsidian Therapeutics appointed Dana Alexander as the Chief Technology Officer, bringing in new expertise that can be leveraged to explore partnership opportunities and drive innovation.

Cutting-Edge Technology Obsidian Therapeutics utilizes advanced technologies such as its cytoDriveTM platform in developing controllable cell and gene therapies, offering a unique value proposition that can attract collaboration from industry leaders.

Market Engagement Obsidian Therapeutics actively participates in prestigious events like the J.P. Morgan Healthcare Conference, presenting an excellent opportunity to network, showcase products, and potentially secure partnerships or investments.

Clinical Success Showcase Obsidian Therapeutics successfully launched OBX-115, an engineered TIL cell therapy with positive interim clinical data, demonstrating credibility in the biotechnology research sector and attracting interest from potential clients or collaborators.

Obsidian Therapeutics Tech Stack

Obsidian Therapeutics uses 8 technology products and services including Carta, CookieYes, MySQL, and more. Explore Obsidian Therapeutics's tech stack below.

  • Carta
    Accounting And Finance
  • CookieYes
    Cookie Compliance
  • MySQL
    Database
  • Microsoft Excel
    Editors
  • Twitter Emoji (Twemoji)
    Font Scripts
  • PWA
    Miscellaneous
  • Python
    Programming Languages
  • Google Tag Manager
    Tag Management

Media & News

Obsidian Therapeutics's Email Address Formats

Obsidian Therapeutics uses at least 1 format(s):
Obsidian Therapeutics Email FormatsExamplePercentage
FLast@obsidiantx.comJDoe@obsidiantx.com
90%
First.Last@obsidiantx.comJohn.Doe@obsidiantx.com
4%
LastFirst@obsidiantx.comDoeJohn@obsidiantx.com
4%
First_Last@obsidiantx.comJohn_Doe@obsidiantx.com
2%

Frequently Asked Questions

Where is Obsidian Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Obsidian Therapeutics's main headquarters is located at 1030 Massachusetts Avenue Suite 400 Cambridge, MA 02138 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Obsidian Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Obsidian Therapeutics's official website is obsidiantx.com and has social profiles on LinkedIn.

How much revenue does Obsidian Therapeutics generate?

Minus sign iconPlus sign icon
As of April 2025, Obsidian Therapeutics's annual revenue reached $35M.

What is Obsidian Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Obsidian Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Obsidian Therapeutics have currently?

Minus sign iconPlus sign icon
As of April 2025, Obsidian Therapeutics has approximately 119 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: M. J.Chief Development Officer (cdo): P. H.Chief Financial Officer: J. T.. Explore Obsidian Therapeutics's employee directory with LeadIQ.

What industry does Obsidian Therapeutics belong to?

Minus sign iconPlus sign icon
Obsidian Therapeutics operates in the Biotechnology Research industry.

What technology does Obsidian Therapeutics use?

Minus sign iconPlus sign icon
Obsidian Therapeutics's tech stack includes CartaCookieYesMySQLMicrosoft ExcelTwitter Emoji (Twemoji)PWAPythonGoogle Tag Manager.

What is Obsidian Therapeutics's email format?

Minus sign iconPlus sign icon
Obsidian Therapeutics's email format typically follows the pattern of . Find more Obsidian Therapeutics email formats with LeadIQ.

How much funding has Obsidian Therapeutics raised to date?

Minus sign iconPlus sign icon
As of April 2025, Obsidian Therapeutics has raised $161M in funding. The last funding round occurred on Apr 03, 2024 for $161M.

When was Obsidian Therapeutics founded?

Minus sign iconPlus sign icon
Obsidian Therapeutics was founded in 2015.
Obsidian Therapeutics

Obsidian Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

Obsidian Therapeutics is pioneering controllable cell and gene therapies to deliver transformative outcomes for patients with intractable diseases. Obsidian’s programs apply our cytoDriveTM technology in cell and gene therapy products to control expression of proteins for enhanced therapeutic efficacy, including our lead program cytoTIL15 engineered to make TILs more effective for more patients.
 
Our aspirations are high, and we’re built to deliver – well-funded with blue chip investors, engaged field-leading advisors, strong partnerships with industry leaders, and a highly experienced, dynamic, innovative and collaborative team, collectively focused on delivering transformative therapies in areas of greatest clinical need.

Located in the heart of Cambridge with a new laboratory facility in Bedford, we’re proud of our diverse talented team and committed to cultivating an environment of inclusion where we strive to instill a strong sense of belonging, and support each Obsidianite to continuously learn and contribute their best work.  We offer competitive salary and benefits, and potential for employee ownership through stock options.

Section iconCompany Overview

Headquarters
1030 Massachusetts Avenue Suite 400 Cambridge, MA 02138 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $161M

    Obsidian Therapeutics has raised a total of $161M of funding over 3 rounds. Their latest funding round was raised on Apr 03, 2024 in the amount of $161M.

  • $10M$50M

    Obsidian Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $161M

    Obsidian Therapeutics has raised a total of $161M of funding over 3 rounds. Their latest funding round was raised on Apr 03, 2024 in the amount of $161M.

  • $10M$50M

    Obsidian Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.